Development of a BCS Class II Drug Microemulsion for Oral Delivery: Design, Optimization, and Evaluation

Figure 5

Comparative results of the apparent permeability coefficient of fenofibrate free drug and optimized ME using Sartorius SM 16751 and EGS models.